Literature DB >> 21389217

Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy.

Yoichi Kondo1, Jessica M Adams, Marie T Vanier, Ian D Duncan.   

Abstract

Whether microglia and macrophages are beneficial or harmful in many neurological disorders, including demyelinating diseases such as multiple sclerosis and the leukodystrophies, is currently under debate. Answering this question is of special interest in globoid cell leukodystrophy (GLD), a genetic fatal demyelinating disease, because its rapidly progressive demyelination in the nervous system is accompanied by a characteristic accumulation of numerous globoid macrophages. Therefore, we cross-bred the twitcher (twi) mouse, a bona fide model of GLD, with the macrophage-deficient osteopetrotic mutant and studied the resultant macrophage-deficient twitcher (twi+op) mouse. The twi+op mouse had few microglia and macrophages in the white matter and, interestingly, showed a more severe clinical phenotype compared to the twi mouse. The number of nonmyelinated axons in the spinal cord was significantly higher in twi+op mice than in twi mice at 45 d old. The difference appeared to be due to impaired remyelination in twi+op mice rather than accelerated demyelination. Quantitative reverse transcription PCR and immunohistochemical studies revealed that the recruitment of oligodendrocyte progenitor cells in response to demyelination was compromised in twi+op mice. Increased myelin debris in the white matter parenchyma of twi+op mice suggested that phagocytosis by macrophages may play an important role in promoting remyelination. Macrophage markers for both protective and destructive phenotypes were significantly upregulated in the spinal cord of twi mice but were close to normal in twi+op mice due to the reduced macrophage number. The overall effects of macrophages in GLD appear to be beneficial to myelin by promoting myelin repair.

Entities:  

Mesh:

Year:  2011        PMID: 21389217      PMCID: PMC3086602          DOI: 10.1523/JNEUROSCI.6344-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  73 in total

Review 1.  De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway.

Authors:  Alfred H Merrill
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

2.  Delayed clinical and pathological signs in twitcher (globoid cell leukodystrophy) mice on a C57BL/6 x CAST/Ei background.

Authors:  Sangita Biswas; Homigol Biesiada; Todd D Williams; Steven M LeVine
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

Review 3.  Macrophage polarization comes of age.

Authors:  Alberto Mantovani; Antonio Sica; Massimo Locati
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

4.  Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher.

Authors:  Ikuko Mohri; Masako Taniike; Hidetoshi Taniguchi; Takahisa Kanekiyo; Kosuke Aritake; Takashi Inui; Noriko Fukumoto; Naomi Eguchi; Atsuko Kushi; Hitoshi Sasai; Yoshihide Kanaoka; Keiichi Ozono; Shuh Narumiya; Kinuko Suzuki; Yoshihiro Urade
Journal:  J Neurosci       Date:  2006-04-19       Impact factor: 6.167

Review 5.  Can the immune system be harnessed to repair the CNS?

Authors:  Phillip G Popovich; Erin E Longbrake
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

6.  Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease.

Authors:  Shailendra Giri; Manu Jatana; Ramandeep Rattan; Je-Seong Won; Inderjit Singh; Avtar K Singh
Journal:  FASEB J       Date:  2002-05       Impact factor: 5.191

7.  Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase.

Authors:  K Suzuki; Y Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

8.  p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.

Authors:  Daniel C Bullard; Xianzhen Hu; Jillian E Adams; Trenton R Schoeb; Scott R Barnum
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

9.  Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model.

Authors:  Kuriko Kagitani-Shimono; Ikuko Mohri; Yasushi Fujitani; Kinuko Suzuki; Keiichi Ozono; Yoshihiro Urade; Masako Taniike
Journal:  J Neuroinflammation       Date:  2005-04-06       Impact factor: 8.322

10.  Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.

Authors:  Mark R Kotter; Wen-Wu Li; Chao Zhao; Robin J M Franklin
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

View more
  32 in total

Review 1.  A microglial hypothesis of globoid cell leukodystrophy pathology.

Authors:  Alexandra M Nicaise; Ernesto R Bongarzone; Stephen J Crocker
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 2.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 3.  Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System.

Authors:  Violeta Chitu; Şölen Gokhan; Sayan Nandi; Mark F Mehler; E Richard Stanley
Journal:  Trends Neurosci       Date:  2016-04-12       Impact factor: 13.837

Review 4.  Cell Therapeutic Strategies for Spinal Cord Injury.

Authors:  Pinghui Zhou; Jingjing Guan; Panpan Xu; Jingwen Zhao; Changchun Zhang; Bin Zhang; Yingji Mao; Wenguo Cui
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-16       Impact factor: 4.730

Review 5.  The myelin mutants as models to study myelin repair in the leukodystrophies.

Authors:  Ian D Duncan; Yoichi Kondo; Su-Chun Zhang
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

6.  An in vitro model for the study of cellular pathophysiology in globoid cell leukodystrophy.

Authors:  Kumiko I Claycomb; Kasey M Johnson; Ernesto R Bongarzone; Stephen J Crocker
Journal:  J Vis Exp       Date:  2014-10-21       Impact factor: 1.355

7.  Spontaneous optic nerve compression in the osteopetrotic (op/op) mouse: a novel model of myelination failure.

Authors:  Yoichi Kondo; Jenna M Ramaker; Abigail B Radcliff; Simona Baldassari; Joshua A Mayer; James N Ver Hoeve; Chuan-Li Zhang; Shing-Yan Chiu; Raymond J Colello; Ian D Duncan
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

8.  Oxidative stress as a therapeutic target in globoid cell leukodystrophy.

Authors:  Jacqueline A Hawkins-Salsbury; Elizabeth Y Qin; Adarsh S Reddy; Carole A Vogler; Mark S Sands
Journal:  Exp Neurol       Date:  2012-07-28       Impact factor: 5.330

9.  MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology.

Authors:  Kumiko Ijichi; Graham D Brown; Craig S Moore; Jean-Pyo Lee; Paige N Winokur; Roberto Pagarigan; Evan Y Snyder; Ernesto R Bongarzone; Stephen J Crocker
Journal:  Glia       Date:  2013-02-13       Impact factor: 7.452

10.  Aberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functions.

Authors:  Kumiko I Claycomb; Paige N Winokur; Kasey M Johnson; Alexandra M Nicaise; Anthony W Giampetruzzi; Anthony V Sacino; Evan Y Snyder; Elisa Barbarese; Ernesto R Bongarzone; Stephen J Crocker
Journal:  J Neuropathol Exp Neurol       Date:  2014-10       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.